280 related articles for article (PubMed ID: 17504311)
1. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
Bethune M
Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
[TBL] [Abstract][Full Text] [Related]
2. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
; Prabhu M; Kuller JA; Biggio JR
Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
[TBL] [Abstract][Full Text] [Related]
3. The role of the second trimester genetic sonogram in screening for fetal Down syndrome.
Benacerraf BR
Semin Perinatol; 2005 Dec; 29(6):386-94. PubMed ID: 16533652
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of ultrasound markers in screening fetal trisomy 21].
Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
[TBL] [Abstract][Full Text] [Related]
5. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography.
Vintzileos AM; Egan JF
Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
[TBL] [Abstract][Full Text] [Related]
7. Genetic sonography after first-trimester Down syndrome screening.
Krantz DA; Hallahan TW; Macri VJ; Macri JN
Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
[TBL] [Abstract][Full Text] [Related]
8. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses.
Paladini D; Sglavo G; Pastore G; Masucci A; D'Armiento MR; Nappi C
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):191-5. PubMed ID: 21793087
[TBL] [Abstract][Full Text] [Related]
9. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy.
Nyberg DA; Souter VL; El-Bastawissi A; Young S; Luthhardt F; Luthy DA
J Ultrasound Med; 2001 Oct; 20(10):1053-63. PubMed ID: 11587012
[TBL] [Abstract][Full Text] [Related]
10. Influence of second-trimester ultrasound markers for Down syndrome in pregnant women of advanced maternal age.
Rumi Kataguiri M; Araujo Júnior E; Silva Bussamra LC; Nardozza LM; Fernandes Moron A
J Pregnancy; 2014; 2014():785730. PubMed ID: 24795825
[TBL] [Abstract][Full Text] [Related]
11. Humeral shortening in second-trimester fetuses with Down syndrome.
Benacerraf BR; Neuberg D; Frigoletto FD
Obstet Gynecol; 1991 Feb; 77(2):223-7. PubMed ID: 1824870
[TBL] [Abstract][Full Text] [Related]
12. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
[TBL] [Abstract][Full Text] [Related]
13. [Role of "subtle" ultrasonographic signs during antenatal screening for trisomy 21 during the second trimester of pregnancy: meta-analysis and CPDPN protocol of the Grenoble University Hospital].
Viossat P; Cans C; Marchal-André D; Althuser M; Tomasella T; Pons JC; Jouk PS
J Gynecol Obstet Biol Reprod (Paris); 2005 May; 34(3 Pt 1):215-31. PubMed ID: 16012382
[TBL] [Abstract][Full Text] [Related]
14. [The genetic sonogram].
Ben-Ami M; Jadaon JE
Harefuah; 2009 Jul; 148(7):455-9, 474. PubMed ID: 19848335
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound screening: Status of markers and efficacy of screening for structural abnormalities.
Rao R; Platt LD
Semin Perinatol; 2016 Feb; 40(1):67-78. PubMed ID: 26777687
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening.
Odibo AO; Sehdev HM; Gerkowicz S; Stamilio DM; Macones GA
Am J Obstet Gynecol; 2008 Sep; 199(3):281.e1-5. PubMed ID: 18771983
[TBL] [Abstract][Full Text] [Related]
17. Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary?
Ting YH; Lao TT; Lau TK; Chung MK; Leung TY
J Matern Fetal Neonatal Med; 2011 Apr; 24(4):555-8. PubMed ID: 21375370
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.
Smith-Bindman R; Hosmer W; Feldstein VA; Deeks JJ; Goldberg JD
JAMA; 2001 Feb; 285(8):1044-55. PubMed ID: 11209176
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
20. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome.
Smith-Bindman R; Chu P; Goldberg JD
Prenat Diagn; 2007 Jun; 27(6):535-44. PubMed ID: 17367102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
